CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Option exercise | +43,248 | $2.69 | $116K | 345,307 |
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Sale | −43,248 | $11.22 | $485K | 302,059 |
| 2022-08-25 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −43,248 | 73,601 | ||
| 2022-08-22 | Khan Ruhi Ahmad Chief Business Officer | Grant or award · Option to purchase Common Stock | +70,000 | 70,000 | ||
| 2022-08-22 | Fischesser Ryan VP of Finance and Controller | Grant or award | +4,848 | 120,366 | ||
| 2022-05-18 | JOHNSON DAVID LEE Director | Grant or award · Option to purchase Common Stock | +44,000 | 44,000 | ||
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise | +68,306 | $1.81 | $124K | 295,945 |
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise | +6,114 | $2.69 | $16K | 302,059 |
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −68,306 | 3,534 | ||
| 2022-05-13 | Kanner Steven Chief Scientific Officer | Option exercise · Option to purchase Common Stock | −6,114 | 116,849 | ||
| 2022-05-09 | Haurwitz Rachel E. President and CEO | Option exercise | +10,000 | $2.96 | $30K | 20,000 |
| 2022-05-09 | Haurwitz Rachel E. President and CEO | Option exercise · Option to purchase Common Stock | −10,000 | 116,350 | ||
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Option exercise | +1,136 | $2.69 | $3K | 114,380 |
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Option exercise | +1,138 | $4.11 | $5K | 115,518 |
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −1,136 | 4,543 | ||
| 2022-05-05 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −1,138 | 18,176 | ||
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Option exercise | +1,136 | $2.69 | $3K | 112,106 |
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Option exercise | +1,138 | $4.11 | $5K | 113,244 |
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −1,136 | 5,679 | ||
| 2022-03-15 | Fischesser Ryan VP of Finance and Controller | Option exercise · Option to purchase Common Stock | −1,138 | 19,314 |
Page 6 of 9 · 177 trades